Home » Topics » Regulatory

Regulatory
RSS

New treatment regimens of Zithromax recommended for approval in pediatric ear infections

Nov. 14, 2001

FDA approves labeling change for Rhinocort Aqua

Nov. 13, 2001

Management of focal spasticity is latest indication granted for Botox in Canada

Nov. 12, 2001

Positive phase IV results reported for Olux in mild to moderate body psoriasis

Nov. 8, 2001

Novartis seeks European marketing authorization for Myfortic

Nov. 7, 2001

New tablet formulations of linezolid claimed by Pharmacia

Nov. 6, 2001

Celebrex indications expanded with recent FDA approval

Nov. 6, 2001

Oculex commences phase II trial of Posurdex for PME

Oct. 30, 2001

Shire's once-daily Adderall XR launched in U.S. for treatment of ADHD

Oct. 30, 2001

First regulatory approval obtained for Viread

Oct. 30, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 11, 2025.
3Sbio revs on with phase II data in tight PD-1/VEGF bispecific race
BioWorld
3Sbio Inc. reported interim phase II study results of its PD-1/VEGF bispecific antibody, SSGJ-707 – a “fabulous” asset, according to Pfizer Inc. CEO Albert...
Corestemchemon preps US BLA filing for stem cell ALS therapy
BioWorld Asia
Corestemchemon Inc. is planning to file a BLA for Neuronata-R (lenzumestrocel) by the end of 2025 to gain accelerated approval from the U.S. FDA, company...
Merck wins FDA approval in pediatric RSV and steps into CDC uncertainty
BioWorld
With the U.S. FDA’s approval of Enflonsia (clesrovimab) to prevent respiratory syncytial virus (RSV) infection lower respiratory tract disease in newborns and...